Abstract
The ING1 is a newly cloned putative tumor-suppressor gene, which is involved in the p53 signaling pathway. We found decreased expression of ING1 mRNA in 4 of 5 T-cell lines and 5 of 11 B-cell lines including two Burkitt lymphomas and two myelomas. These observations suggest that decreased ING1 expression might play an important role in the development or progression of some lymphoid tumors. Polymerase chain reaction-SSCP and sequencing analyses found neither point mutations nor small deletions in the ING1 gene, suggesting that decreased expression is due to transcriptional or post-transcriptional mechanisms.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Cell Cycle Proteins
-
DNA-Binding Proteins
-
Gene Expression Regulation, Neoplastic*
-
Genes, Tumor Suppressor*
-
Growth Inhibitors / genetics
-
Humans
-
Inhibitor of Growth Protein 1
-
Intracellular Signaling Peptides and Proteins
-
Jurkat Cells
-
Leukemia / genetics
-
Lymphoma / genetics
-
Nuclear Proteins
-
Proteins / genetics*
-
RNA, Messenger / genetics*
-
Reverse Transcriptase Polymerase Chain Reaction
-
Transcription, Genetic*
-
Tumor Cells, Cultured
-
Tumor Suppressor Proteins
Substances
-
Cell Cycle Proteins
-
DNA-Binding Proteins
-
Growth Inhibitors
-
ING1 protein, human
-
Inhibitor of Growth Protein 1
-
Intracellular Signaling Peptides and Proteins
-
Nuclear Proteins
-
Proteins
-
RNA, Messenger
-
Tumor Suppressor Proteins